Senti Biosciences, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SNTI Company Description
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
SNTI Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SNTI Smart Score
Score Breakdown
SNTI Company Description
Show More
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SNTI by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SNTI's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on SNTI's company Twitter account
WallStreetBets
Number of mentions of SNTI in WallStreetBets Daily Discussion
SNTI News
Recent insights relating to SNTI
CNBC Recommendations
Recent picks made for SNTI stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SNTI
Corporate Flights
Flights by private jets registered to SNTI
Our Analysis